Serum xylosyltransferase 1 level increases during early posttraumatic osteoarthritis in mice with high bone forming potential

Item

http://www.wikidata.org/entity/Q35870749

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Serum xylosyltransferase 1 lev ...... th high bone forming potential

@ast

Serum xylosyltransferase 1 lev ...... th high bone forming potential

@en

type

Item

label

Serum xylosyltransferase 1 lev ...... th high bone forming potential

@ast

Serum xylosyltransferase 1 lev ...... th high bone forming potential

@en

prefLabel

Serum xylosyltransferase 1 lev ...... th high bone forming potential

@ast

Serum xylosyltransferase 1 lev ...... th high bone forming potential

@en

P1476

Serum xylosyltransferase 1 lev ...... th high bone forming potential

@en

P2093

Catherine B Kirn-Safran

http://www.w3.org/2001/XMLSchema#string

Erica M Selva

http://www.w3.org/2001/XMLSchema#string

Kerry A Falgowski

http://www.w3.org/2001/XMLSchema#string

Padma P Srinivasan

http://www.w3.org/2001/XMLSchema#string

Sarah Y McCoy

http://www.w3.org/2001/XMLSchema#string

P2860

Aggrecanases and cartilage matrix degradation

Modulation of xylosyltransferase I expression provides a mechanism regulating glycosaminoglycan chain synthesis during cartilage destruction and repair

Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy

Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis.

Cloning and recombinant expression of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II.

The formation of extracellular matrix during chondrogenic differentiation of mesenchymal stem cells correlates with increased levels of xylosyltransferase I.

Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254).

The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors.

Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease.

Biochemical markers of bone turnover and their association with bone marrow lesions.

P304

224-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BONE.2011.11.012

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

William R Thompson

P577

2011-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51857353

http://www.w3.org/2001/XMLSchema#string

P698

22146554

http://www.w3.org/2001/XMLSchema#string

P921

osteoarthritis

P932

3319505

http://www.w3.org/2001/XMLSchema#string